{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:50:05Z","timestamp":1774914605140,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.clim.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T12:48:05Z","timestamp":1494506885000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["IL-10-producing regulatory B cells (B10 cells), IL-17 + T cells and autoantibodies in systemic sclerosis"],"prefix":"10.1016","volume":"184","author":[{"given":"Athanasios","family":"Mavropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Simopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3314","authenticated-orcid":false,"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.04.013_bb0005","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.013_bb0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.013_bb0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.013_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2017.04.013_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.013_bb0030","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.013_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.013_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/156652412800620057","article-title":"IL-10 producing regulatory B cells in mice and humans: state of the art","volume":"12","author":"Bouaziz","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.clim.2017.04.013_bb0045","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","volume":"14","author":"Carter","year":"2012","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.clim.2017.04.013_bb0050","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0055","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"issue":"15 Suppl 1","key":"10.1016\/j.clim.2017.04.013_bb0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","author":"Kalampokis","year":"2013","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.clim.2017.04.013_bb0065","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.013_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.013_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.04.013_bb0080","article-title":"Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis","author":"Marou","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.013_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-61779-367-7_19","article-title":"Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases","volume":"806","author":"Mavropoulos","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2017.04.013_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.12483","article-title":"Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies","volume":"180","author":"Aybar","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0095","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4049\/jimmunol.1303397","article-title":"CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis","volume":"193","author":"Sheng","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0100","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0105","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1302897","article-title":"Regulatory CD4+ T cells promote B cell anergy in murine lupus","volume":"192","author":"Liu","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0110","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4049\/jimmunol.1002942","article-title":"Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells","volume":"186","author":"Jang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0115","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/annrheumdis-2012-202986","article-title":"Regulatory B cells in ANCA-associated vasculitis","volume":"72","author":"Wilde","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.013_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.04.013_bb0130","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0135","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.013_bb0140","doi-asserted-by":"crossref","first-page":"e85032","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.013_bb0145","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.clim.2017.04.013_bb0150","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2017.04.013_bb0155","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar1038","article-title":"IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase\/Akt-dependent pathways","volume":"6","author":"Hwang","year":"2004","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.clim.2017.04.013_bb0160","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.4049\/jimmunol.0901499","article-title":"Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17","volume":"183","author":"Blaho","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0165","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1030560","article-title":"Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma","volume":"4","author":"Ferretti","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clim.2017.04.013_bb0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.013_bb0180","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2017.04.013_bb0185","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci. Transl. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616305654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616305654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T19:26:51Z","timestamp":1535830011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616305654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":37,"alternative-id":["S1521661616305654"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.04.013","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}